A phase II study of daily encorafenib in combination with biweekly cetuximab in patients with BRAF V600E mutated metastatic colorectal cancer: the NEW BEACON study

por Eriksen, Martina, Pfeiffer, Per, Rohrberg, Kristoffer Staal, Yde, Christina Westmose, Petersen, Lone Nørgård, Poulsen, Laurids Østergaard, Qvortrup, Camilla
Publicado 2022